From simple breath to life-saving answers
Point-of-care detection of early-stage lung cancer
in just minutes
From simple breath to life-saving answers
Point-of-care detection of early-stage lung cancer
in just minutes
Making lung cancer screening safer, simpler, and more accessible
Benefiting patients, empowering healthcare providers, easing pressure on health systems, and improving outcomes for society as a whole
Early Detection of Lung Cancer Saves Lives
But early-stage lung cancer displays no specific symptoms, making detection difficult.
To enable early detection, we develop breath-testing technologies designed to extract relevant signals of lung cancer from the breath.
We are dedicated to help saving lives by making affordable, easy-to-use lung cancer screening widely available.
Early Detection of Lung Cancer Saves Lives
But early-stage lung cancer displays no specific symptoms, making detection difficult.
To enable early detection, we develop breath-testing technologies designed to extract relevant signals of lung cancer from the breath.
We are dedicated to help saving lives by making affordable, easy-to-use lung cancer screening widely available.
Just Breathe to Know
Achievements
Proud semifinalist of EIT Health Catapult 2023
April 2024
Winner of Special Industry Award by AstraZeneca at the EIT Health Catapult Finals
June 2024
July 2025
What we offer
Inflammacheck®
Just breathe: Inflammacheck® creates a comprehensive Breath Print from exhaled condensate and gas-phase signals, with factory-calibrated sensors and AI delivering accurate, affordable lung-cancer risk results at the point of care in just minutes.
Lung Cancer Screening
Screening without barriers; Portable, affordable, and easy to use, Inflammacheck® widens access in GP and outreach settings—bringing early detection to underserved communities and reducing missed opportunities for life-saving treatment.
Team
Trusted hands for a critical task; Proven leadership in medtech, pharma, and the NHS; rigorous engineering and quality systems; clear financing and market access. We know how to turn breakthrough diagnostics into every day, point-of-care practice.